Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its QTORIN product candidates are developed to accommodate the cargo at high concentrations in order to drive sufficient drug to its target deep in the epidermis and dermis. The Company's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin), is being evaluated in the Phase III SELVA clinical trial in microcystic lymphatic malformations and the Phase II TOIVA clinical trial in cutaneous venous malformations.
Find out what a historical investment in Palvella Therapeutics, Inc. would be worth today using our PVLA stock calculator.
Buying PVLA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Palvella Therapeutics, Inc. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in PVLA
What is the ticker symbol of Palvella Therapeutics, Inc.?
The ticker symbol for Palvella Therapeutics, Inc. is PVLA.
How much is one share of PVLA?
One share of PVLA is valued at $145.77 as of 20 November 2026.
What is the market capitalisation of Palvella Therapeutics, Inc. PVLA?
As of 20 November 2026 Palvella Therapeutics, Inc. has a market cap of $2.14B.
What is the 52-week high for Palvella Therapeutics, Inc. stock?
The Palvella Therapeutics, Inc. 52-week high stock price is $179.95.
What is the 52-week low for Palvella Therapeutics, Inc. stock?
The Palvella Therapeutics, Inc. 52-week low stock price is $72.23.
Can I buy PVLA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PVLA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PVLA on Stake
Buy PVLA from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of PVLA from only US$10 with fractional shares